[A case of successfully treated lower rectal cancer with both inguinal lymph nodes by chemoradiotherapy]

Gan To Kagaku Ryoho. 2010 Nov;37(12):2611-3.
[Article in Japanese]

Abstract

We report a case of successfully treated lower rectal cancer with both inguinal lymph nodes by chemoradiotherapy. A 59-year-old man presented with anal pain. A colonoscopy revealed primary rectal cancer. The histological diagnosis was well to moderately differentiated adenocarcinoma. A computed tomography showed metastases to pararectal, both inguinal lymph nodes and right external iliac. After a ileostomy construction was done, he was treated with intensity modulated radiotherapy (a total 50.4 Gy) and chemotherapy with FOLFOX. The primary tumor had completely disappeared, and metastases to lymph nodes showed a remarkable shrinkage after the chemoradiotherapy. Nine months after radiation therapy, however, multiple lung and liver metastases were observed by a computed tomography, which were treated by systemic chemotherapy with FOLFOX and bevacizumab. The primary tumor and metastases to lymph nodes are still controlled well for 2 years after the initial chemoradiotherapy.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adenocarcinoma / pathology
  • Adenocarcinoma / therapy*
  • Angiogenesis Inhibitors / administration & dosage
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bevacizumab
  • Combined Modality Therapy
  • Fluorouracil / therapeutic use
  • Humans
  • Ileostomy
  • Inguinal Canal
  • Leucovorin / therapeutic use
  • Lymphatic Metastasis*
  • Male
  • Middle Aged
  • Organoplatinum Compounds / therapeutic use
  • Radiotherapy, Intensity-Modulated
  • Rectal Neoplasms / pathology
  • Rectal Neoplasms / therapy*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Organoplatinum Compounds
  • Bevacizumab
  • Leucovorin
  • Fluorouracil

Supplementary concepts

  • Folfox protocol